Hap Trading, LLC Novo Nordisk A S Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2025 Aug 13, 2025	SELL	$58.08 - $81.05 $284,592 - $397,145	-4,900 Reduced 17.44%	23,200 $90.9 Million
Q1 2025 May 14, 2025	BUY	$69.3 - $90.95 $1.09 Million - $1.43 Million	15,700 Added 126.61%	28,100 $42.7 Million
Q4 2024 Feb 13, 2025	BUY	$85.0 - $120.04 $1.05 Million - $1.49 Million	12,400 New	12,400 $11.8 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $1.19 Million - $1.43 Million	13,600 New	13,600 $50.7 Million
Q1 2022 May 12, 2022	SELL	$93.1 - $112.54 $6.13 Million - $7.41 Million	-65,800 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $6.31 Million - $7.7 Million	65,800 New	65,800 $160,000
Q3 2019 Nov 12, 2019	SELL	$47.54 - $53.43 $3.29 Million - $3.7 Million	-69,200 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$46.79 - $52.47 $3.24 Million - $3.63 Million	69,200 New	69,200 $26,000

1,694

293M

13.8M

19.7M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $105B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.